178 related articles for article (PubMed ID: 27887801)
1. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.
Kountouras J; Polyzos SA; Katsinelos P; Zeglinas C; Artemaki F; Tzivras D; Vardaka E; Gavalas E; Romiopoulos I; Simeonidou C; Grigoriadis N; Kountouras C; Dardiotis E; Deretzi G
Int J Cardiol; 2017 Feb; 229():17-18. PubMed ID: 27887801
[No Abstract] [Full Text] [Related]
2. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
Zullo A; De Francesco V; Hassan C
J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
[No Abstract] [Full Text] [Related]
3.
Gravina AG; Zagari RM; De Musis C; Romano L; Loguercio C; Romano M
World J Gastroenterol; 2018 Aug; 24(29):3204-3221. PubMed ID: 30090002
[No Abstract] [Full Text] [Related]
4. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
5. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
[TBL] [Abstract][Full Text] [Related]
6. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
7. Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?
Zuin M; Rigatelli G; Del Favero G; Picariello C; Meggiato T; Conte L; Faggian G; Zuliani G; Roncon L
Int J Cardiol; 2016 Nov; 223():711-712. PubMed ID: 27573593
[No Abstract] [Full Text] [Related]
8. [The results of dynamic observation over patients with stomach and duodenum ulcer diseases after Helicobacter pylori eradication].
Kas'ianenko VI
Eksp Klin Gastroenterol; 2007; (4):19-24. PubMed ID: 18409486
[No Abstract] [Full Text] [Related]
9. Eradication therapy for Helicobacter pylori.
Vakil N; Megraud F
Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori and ulcer disease: diagnosis and treatment 1995].
Kayser S; Fried M
Praxis (Bern 1994); 1996 Sep; 85(39):1197-200. PubMed ID: 8927903
[TBL] [Abstract][Full Text] [Related]
11. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
Sarikaya M; Filik L; Doğan Z; Ergül B
Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
[No Abstract] [Full Text] [Related]
12. Helicobacter pylori infection and diabetes mellitus.
Polyzos SA; Papaefthymiou A; Doulberis M; Mavridoglou G; Kountouras J
Diabetes Metab Syndr; 2021; 15(3):845-846. PubMed ID: 33873053
[No Abstract] [Full Text] [Related]
13. Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?
Kountouras J; Polyzos SA; Katsinelos P; Zeglinas C; Artemaki F; Tzivras D; Vardaka E; Gavalas E; Romiopoulos I; Simeonidou C; Grigoriadis N; Kountouras C; Dardiotis E; Deretzi G
Int J Cardiol; 2017 Apr; 233():92. PubMed ID: 28043671
[No Abstract] [Full Text] [Related]
14. Helicobacter pylori eradication, endoscopic surveillance, and gastric cancer.
Cannizzaro R; De Paoli P
Am J Gastroenterol; 2009 Dec; 104(12):3100-1; author reply 3101-2. PubMed ID: 19956127
[No Abstract] [Full Text] [Related]
15. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
Lengyel G; Zsolt T
Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
Dzierzanowska-Fangrat K; Dzierzanowska D
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():5-14. PubMed ID: 17033102
[TBL] [Abstract][Full Text] [Related]
17. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
[TBL] [Abstract][Full Text] [Related]
18. [Role of Helicobacter pylori eradication in the prevention of gastric cancer].
Tsukanov VV; Amel'chugova OS; Kasparov ÉV; Butorin NN; Vasiutin AV; Tonkikh IuL; Tret'iakova OV
Ter Arkh; 2014; 86(8):124-7. PubMed ID: 25306759
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Helicobacter pylori isolates of dyspeptic Nigerian patients.
Abdulrasheed A; Lawal OO; Abioye-Kuteyi EA; Lamikanra A
Trop Gastroenterol; 2005; 26(2):85-8. PubMed ID: 16225052
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori: what schemes of eradication are essential today?].
Maev IV; Samsonov AA; Golubev NN
Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
